Rapid Micro Biosystems (RPID) Net Margin (2020 - 2026)

Rapid Micro Biosystems has disclosed Net Margin across 7 years of filings, most recently posting 178.39% for Q1 2026.

• Net Margin for Q1 2026 came in at 178.39%, down 2207.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 145.81% (up 541.0% YoY), and the FY2025 annual result was 140.3%, up 2685.0% from the prior year.
• Net Margin came in at 178.39% for Q1 2026 at Rapid Micro Biosystems, down from 110.77% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 110.77% in Q4 2025 to a low of 376.02% in Q4 2022.
• The 5-year median for Net Margin is 190.06% (2024), against an average of 224.63%.
• Across the five-year window, Net Margin tumbled 11237 bps in 2022 and surged 19972 bps in 2023, its largest moves.
• Rapid Micro Biosystems' Net Margin stood at 376.02% in 2022, then jumped by 53 bps to 176.3% in 2023, then surged by 33 bps to 117.62% in 2024, then grew by 6 bps to 110.77% in 2025, then tumbled by 61 bps to 178.39% in 2026.
• The last three Net Margin figures came in at 178.39% (Q1 2026), 110.77% (Q4 2025), and 146.78% (Q3 2025), per Business Quant data.